Great news from our friends at Amlo-Biosciences and a fantastic example of what happens when the collaborative working ethos promoted across Newcastle University, Newcastle Biobanking and The Newcastle Upon Tyne Hospitals NHS Foundation Trust Cellular Pathology department, of which NovoPath is fully integrated, comes to fruition:
Skin cancer: Newcastle University test predicts spread of melanoma – BBC News
AMBRA1 and loricrin test | Melanoma Referral Service (amlo-biosciences.com)